Dana Rizk, MD
Enriched profileAnupam Agarwal Endowed Professor of Medicine; Associate Dean for Clinical Trials, Heersink School of Medicine · University of Alabama at Birmingham (UAB) Heersink School of Medicine
Dana Rizk is Anupam Agarwal Endowed Professor of Medicine; Associate Dean for Clinical Trials, Heersink School of Medicine at University of Alabama at Birmingham (UAB) Heersink School of Medicine. OpenAlex indexes 180 publications with 4,764 citations (h-index 34); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 16 Oct 2026
Dana V. Rizk is Anupam Agarwal Endowed Professor of Medicine at University of Alabama at Birmingham (UAB) Heersink School of Medicine, Division of Nephrology. The public record shows 180 publications with 4,764 citations (h-index 34), centered on Chronic Kidney Disease. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 22 companies.
- Most recent indexed publication: 2026 · Nephrology, dialysis, transplantation
- Top research focus: Chronic Kidney Disease
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 22 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 6 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Public positions
sourced statements on record- Site Principal Investigator
phase 3 APPLAUSE-IgAN trial of iptacopan (Fabhalta) in IgA nephropathy, published in NEJM
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- FAST GFR: Pilot Study to Evaluate the Safety of the FAST GFR Test in Patients.
Sponsor: FAST BioMedical
Industry payments
Updated 16 Oct 2026
22 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Otsuka Pharmaceutical Development & Commercialization, Inc.Program year202517 payments$29,517openpaymentsdata.cms.gov ↗
- Travere Therapeutics, Inc.Program year202511 payments$15,242openpaymentsdata.cms.gov ↗
- Novartis Pharmaceuticals CorporationProgram year20253 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
76.2%Angiotensin receptor blocker (ARB)25.7%Losartan Potassium68%Telmisartan17%Irbesartan16%Part D<11 patientsCalcium channel blocker16.1%Amlodipine Besylate100%Part D≥19 patients+ 5 more classes in this area
Metabolism & gastrointestinal
20.9%SGLT2 inhibitor14.8%Farxiga100%Part D≥11 patientsCorticosteroid3.2%Prednisone100%Part D<11 patients+ 1 more class in this area
Nervous system
2.9%SSRI2.9%Escitalopram Oxalate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 16 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- What do clinical trials teach us about the pathophysiology of human IgA nephropathy?
Nephrology, dialysis, transplantation
Review2026 - Targeting APRIL in the Treatment of IgA Nephropathy.
Clinical journal of the American Society of Nephrology
Article2024
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/dana-rizk-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
kdigo.org/full-kdigo-2025-igan-podcast-series-now-available
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kdigo.org ↗ - Other
asn-online.org/about/bio.aspx
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asn-online.org ↗ - Orcid.org
X (Twitter) handle @DanaRizk1
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →orcid.org ↗ - LinkedIn
LinkedIn profile: Dana Rizk, Professor of Medicine, Nephrology Division; Associate Dean for Clinical Trial Research, Heersink School of Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asn-online.org ↗
- Board certified in Nephrology
American Board of Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providerdirectory.uabmedicine.org ↗ - Residency (including chief residency) and Nephrology Fellowship
Emory University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asn-online.org ↗
Editorial & leadership roles
journal and society appointments- "WIN Faculty" (Women in Nephrology) designation
American Society of Nephrology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asn-online.org ↗ - Member
The Southern Society for Clinical Investigation
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ssciweb.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nephcure.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →asn-online.org ↗
Secondary affiliations
appointments beyond the home institution- Director
Clinical Trials Research, Division of Nephrology, UAB
- Medical Director
UAB Glomerular Kidney Disease Clinic (Kirklin Clinic)
- Medical Director
Clinical Trials Administrative Office, UAB
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providerdirectory.uabmedicine.org ↗ - Attending nephrologist
Birmingham VA Medical Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doctor.webmd.com ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ajkdblog.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hcplive.com ↗
- Medscape InDiscussion podcast series episode with Matthew A. Sparks on IgA nephropathy pathology
presentation, and management (S2 Ep. 3, "Does Your Patient Have IgA Nephropathy?")
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medscape.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →reachmd.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →docwirenews.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Toni Choueiri, MD
Dana-Farber Cancer Institute
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Fred Saad, MD
Centre hospitalier de l'Université de Montréal (CHUM)